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Abstract: 
 
Poly(lactide-co- glycolide) (PLGA) is a versatile biomaterial and is desirable for use in tissue engineering 
applications requiring a degradable matrix or fixation. PLGA degradation rate can be controlled through 
manipulation of the ratio of its constituent monomers PLA (polylactic acid) and PGA (polyglycolic acid). 
When PLGA degrades it can lead to the development of acidic conditions eliciting an inflammatory 
response. We have investigated the addition of biodegradable Magnesium (Mg) particles to a PLGA 
matrix, aiming to achieve neutral byproducts. Within the body Mg degrades into a basic oxide and 
hydrogen gas, so through varying its concentration in a PLGA scaffold it may be possible to determine an 
optimal concentration for pH neutrality. It was also hypothesized that the maintenance of a neutral pH 
during degradation would prolong degradation rate of the composite. It was found that as Mg 
concentration increased, the length of degradation increased from ~35 days (0%wt Mg) to ~75 days 
(10%wt Mg). There was also a proportional shift in pH toward the basic end of the spectrum. In order to 
assess neutralization a simulated in vivo degradation study was performed. It was found that the addition 
of Mg (5%wt Mg) prolonged degradation from ~40 days to ~80 days and kept pH in a fairly neutral range 
(6-8.5 versus 4-7.5 without Mg). Increasing concentration of Mg was also found to increase the modulus 
of elasticity of composites. During the development of the PLGA-Mg composites agglomeration of the Mg 
particles was observed. Agglomeration presents potential issues for the composites including variable 
mechanics and formation of hydrogen gas pockets in the body. In order to overcome this Mg particles 
were modified with a hydrophobic self assembling monolayer. The intention of the layer was to improve 
particle integration and add a protective coating against degradation. Assessment by micrographs 
revealed some degree of improvement in 10%wt Mg composites where hydrogen gas formation was 
reduced. In an degradation study modification wasn’t found to have any consistent observable difference 
on degradation behavior. Further testing must performed to assess whether modification was successful.  
 
vi 
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Chapter One: An Introduction to Polymer-Metal Composites 
 
1.1 PLGA as a Biomaterial 
 
PLGA is clinically approved for a variety of applications including cell scaffolds, drug delivery 
devices, coatings, and fibers both as a reinforcement and a matrix [1]. PLGA is desirable as a 
material due to its tunable properties, which can be controlled through manipulation of the ratio 
of its constituent monomers, Lactic acid (LA) and Glycolic acid (GA) [2]. LA is hydrophobic while, 
GA is hydrophilic [3]. By increasing the percentage of PLA, PLGA can be made more 
hydrophobic resulting in a slow degradation rate. It has been demonstrated that degradation 
rate can be prolonged from a few weeks to a year for the same amount of PLGA by increasing 
LA composition [3]. In addition, PLGA is also biodegradable. When it degrades it produces Lactic 
Acid and Glycolic Acid, both of which are natural byproducts of metabolic processes of the body 
[2]. In moderate concentrations the body is able to process and remove them.    
 
1.2 Challenges of PLGA 
 
Although Lactic Acid and Glycolic Acid are naturally occurring in the body, they are still acids. At 
high concentrations they are very capable of influencing the local pH. In clinical trials where 
PLGA fixation devices were used in bone, the buildup of acidic byproducts triggered an immune 
response [4]. In some cases, the response may lead to inflammation and implant failure [4]. 
 
When PLGA degrades it does so through bulk degradation. Instead of degrading from the 
surface inward, water diffuses into the polymer and degrades it from the inside [5]. The 
breakdown of the interior leads to the development of a pocket filled with acidic byproducts [5]. 
The collection of these acids leads to the development of a very acidic environment inside the 
structure [5]. This acidic buildup accelerates the degradation due to autocatalysis [3]. Once 
2 
 
structural integrity has been compromised the polymer collapses and the remainder is quickly 
broken down [3].  
 
1.3 Mg as a Biomaterial 
 
Mg as a biomaterial has a range of applications. It is generally used in cardiovascular,  and 
orthopaedic applications  [6][7][8]. It is desirable as a biomaterial because of its mechanics (similar 
to that of bone), osteogenic benefits, and ability to be alloyed to achieve tunable physical and 
mechanical properties [6][7][8] In addition Mg is among a subgroup of metals that are 
biodegradable, the body is able to break them down since they are naturally found within the 
body. Some of these metals are reduced to nontoxic byproducts while others corrode leaving 
toxic particles such as iron oxide. Concentration is often the determining factor when it comes to 
the effects of metal, in low concentrations the body is able to breakdown and clear the material 
without eliciting an immune response or cell death. Biomaterial implants are generally on a large 
enough scale that concentration becomes a concern. By limiting the rate of degradation of these 
metals they can generally be kept within safe limits.  
 
1.4 Challenges of Mg 
 
Mg has several challenges as biomaterial, that become more of a concern with higher 
concentration. Mg, due to its chemical properties, is susceptible to a rapid and uncontrolled 
degradation. In the presence of oxygen or water Mg will form a passivation layer like most 
metals. The thickness of this layer can be categorized by the Pilling-Bedworth ratio, whereas a 
thickness less than 1 is considered very thin, a thickness between 1 and 2 is considered to be 
stable and preventative of further degradation of the metal, and a ratio of 2 or more leads to the 
formation of a thick and unstable layer that will break off and continue to grow, degrading the 
underlying metal [9]. Mg has a ratio of .8 and thus forms a thin layer that is very vulnerable to 
penetration by water [9]. Comparatively titanium (Ti) forms a stable layer due its ratio of 1.5 while 
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iron (Fe) forms a flaking layer of rust due to to its high ratio of 2.1 [9]. Since Mg undergoes rapid 
degradation, it leads to the rapid accumulation of its byproducts, which at high concentrations 
presents a challenge for the body to dissipate.  
 
While the formation of the oxide byproduct can be potentially useful in neutralizing acidic 
byproducts, the formation of the other byproduct, hydrogen gas, can be problematic.  
Hydrogen gas formation in low concentrations is easily handled by the body. However, when 
hydrogen gas is formed rapidly the body is unable to dissipate it. This can lead to the formation 
of gas pockets, an undesirable complication that can cause blood clotting and tissue necrosis 
[10]. In addition to the issue of rapid formation of byproducts, the degradation of Mg means a loss 
of mechanical properties. As the metal degrades it becomes weaker and weaker as would be 
expected. This can present issues when Mg is being used in applications where it’s mechanics 
are required for implant integrity under loading.  
 
 
1.5 PLGA-Mg Composites as a Biomaterial 
 
The use of PLGA-Mg composites has recently become a topic of interest. Most commonly 
PLGA has been used as a protective hydrophobic coating on Mg in order to prevent it from 
degradation [11, 12, 13]. As of recently several groups have investigated the development of a 
three-dimensional (3D) PLGA-Mg scaffold [14, 15, 16]. Ma et al. 2015 demonstrated antibacterial 
effects of PLGA/Tricalcium Phosphate/Mg scaffolds [14]. Brown et al. 2015 used a cylindrical 
PLGA matrix containing Mg particles to prevent bone from receding in jaw void defects [15]. Liu 
et al. has recently patented a degradable neural guidance conduit composed of a PLGA matrix 
containing Mg fibers [16]. Although this composite is being adopted, there are still several 
challenges that need to be addressed before it can be effectively used as a biomaterial. 
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1.6 Challenges of PLGA-Mg Composites 
 
Current studies on PLGA-Mg composites have yet to demonstrate control over the composites 
degradation behavior. With the ability to control the rate and pH at which the composite 
degrades, these studies will allow for development of a material than can be safely used in the 
body. In addition, there is little research on use of Mg to neutralize the acidic byproducts. It has 
not been proven whether Mg oxide can neutralize PLGA byproducts.  
 
In our own lab we have developed PLGA films containing Mg particles.Within them we have 
encountered an issue with agglomeration of Mg particles (Figure 1.1). The agglomeration 
presents two problems for the composites. First, the clumping of Mg particles means that matrix 
has unbalanced consistency, which results in varied mechanics of the composite. In addition 
when the Mg particles degrade they will release their byproducts in one location, making it more 
difficult for the body to dissipate them. This can lead to the development of gas pockets as 
previously discussed in subchapter 1.4.  
 
 
Figure 1.1- A PLGA film with Mg particle (black dots) agglomeration. The glow around the 
particles is caused by light reflecting off the hydrogen gas bubbles.  
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1.7 Mg Alloys 
 
Mg as a metal alone has deficiencies as previously described. To overcome them and improve 
Mg it is frequently alloyed with other metals. A common alloy that may be beneficial as a 
biomaterial is Zinc (Zn) containing alloy ZK61. ZK61 is composed of approximately 95% Mg and 
5% Zn with traces of several other metals (Zirconium, Manganese, Iron, Nickel, Copper, Silicon, 
and Aluminum) [17]. When used as a biomaterial Zn is nearly exclusively used in alloys because 
it has been demonstrated that the addition of Zn can bring several osteogenic benefits to 
biometals. Studies have demonstrated the presence of Zn directly influences mineralization, 
bone cell proliferation, and osteoblast adhesion along with providing antibacterial effects [18, 19, 20, 
21].  
 
1.8 Project Statement 
 
The objective of this research was to overcome the aforementioned challenges of PLGA-Mg 
composites through two specific aims.  
 
1) To control degradation rate, mechanics, and byproduct pH of a PLGA-Mg 
composite through Mg concentration.  
  
 Hypothesis: Mg concentration directly influences composite degradation rate,  
            mechanics, and pH.  
 
2) To chemically modify Mg particles to achieve uniform particle dispersion in PLGA 
and prolong degradation rate.  
 
Hypothesis: By chemically modifying Mg particle surface with a hydrophobic layer,  
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particle distribution can be improved.  
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Chapter Two: Development of PLGA-Mg films 
 
2.1 Film Fabrication 
 
In the study solvent casting process was used to create PLGA-Mg composites. The process 
begins with dissolving (1g) PLGA beads in an organic solvent. At this point Mg particles are 
added for the composites containing Mg. The two or three are then vigorously mixed for 60 
minutes until they have become uniformly mixed into a solution. The solution is then poured into 
a lined 90 mm petri dish at 4°C. This is done so that the solvent is evaporated out slowly, as 
compared to the rate at which it would evaporate at room temperature. It is expected that slow 
evaporation of the solvent reduces the mobility of the particles, it prevents the formation of 
solvent vapor bubble formation as well. The majority of the solvent has been found to evaporate 
within the first 24 hours, after this the films can be brought to room temperature. The films were 
kept in a fume hood for 24-48 hours to further remove the solvent while reducing their exposure 
to water vapor in the air. After this the films were stored in a desiccator until time for use.  
 
2.2 Solvent Selection 
 
In order to improve particle agglomeration in the films the manufacturing process was 
investigated step by step. First it was assessed if there was any influence introduced through 
the solvent. The standard solvent used for dissolving PLGA is dichloromethane (DCM) also 
known as methylene chloride [22]. In order to determine if DCM had any influence on films its 
performance was compared to acetone and chloroform at the same volume of 5 mL, with fixed 
amounts of PLGA (1g) and Mg (3% by weight).  After mixing and allowing the films to dry for 24 
hours at 4°C the films were observed on both the macroscopic and microscopic level. 
Macroscopically the DCM and chloroform films appeared similar, while the acetone film had 
observable agglomeration patterns (Fig. 2.1). The chloroform film appeared to have slightly 
more uniform particle dispersion than the DCM film. Observing the films at 100x magnification it 
was found all three still contained particle agglomeration (Fig. 2.2). Again, chloroform appeared 
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to be the most uniform in terms of particle dispersion, while acetone had the most 
agglomeration. To explain this phenomenon several properties of the solvents were 
investigated. There appears to be a correlation between dielectric constant and the behavior of 
the particle dispersion, as the dielectric constant decreased the agglomeration decreased. 
However the meaning behind this relationship is still unclear. Another possibility is the 
relationship between the rate of solvent evaporation and the viscosity of the films. Although the 
particle agglomeration is due to Mg surface charge, it may be possible that more viscous films 
will make particle movement more difficult and aid in keeping the particles suspended while the 
film solidifies. Based on the results chloroform was chosen for further testing.  
 
Figure 2.1- Images comparing the use of three solvents on Mg particle dispersion A) DCM B) 
Acetone C) Chloroform. Both the DCM and acetone dissolved samples have easily vision 
patterning which indicates particle agglomeration.   
 
 
 
 
Figure 2.2- Micrographs (100x) comparing the use of three solvents on Mg particle dispersion 
A) DCM B) Acetone C) Chloroform. Both the DCM and acetone dissolved samples showed a 
greater amount of particle agglomeration compared to the chloroform sample.   
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2.3 Effect of Solvent Volume 
 
After establishing that chloroform use resulted in superior particle dispersion compared to the 
other solvents, volume of solvent was investigated. Several volumes of solvent were compared 
while maintaining the same amounts of PLGA (1g) and Mg (3% by weight). Volumes of 3 mL, 5 
mL, and 7 mL were compared using a 90 mm petri dish. Like in the solvent comparison, 
samples were compared by observation in terms of Mg particle distribution. On the macroscopic 
level, it was observed that films prepared with 3 mL of solvent were very thick and particle 
dispersion was poor. The composition itself was not even able to cover the entire petri dish, 
which restricted the space the particles could occupy. The 7 mL composition was observed to 
have the opposite effect, the film was very thin (Fig. 2.3). However due to the high amount of 
liquid the particles were able to more freely agglomerate resulting in observable poor dispersion. 
The 5 mL composition appeared to have uniform dispersion on the macroscopic level. Thus it 
was decided that it was clear that 5 mL was superior without the need for examination on the 
microscopic level. By varying the solvent volume it appears that too little solvent restrict the 
particles to one location while too much solvent enables particles to more easily agglomerate. 
An ideal volume falls somewhere in between, for chloroform that volume appears to be 5 mL per 
1g PLGA.  
 
 
Figure 2.3- Images comparing the use of three volumes of solvent on Mg particle dispersion A) 
3 mL B) 5 mL C) 7 mL. The 3 mL sample shows a very tight packing of Mg particles along with 
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the formation of many bubbles. The 5 mL sample has a fairly balanced appearance of particle 
distribution. The 7 mL sample has clear particle agglomeration indicated by distinct dots and 
lines of Mg. 
 
2.4 Effects of Mg Concentration of Composites 
 
After determining the ideal solvent and volume of solvent, in order to meet the first specific aim, 
the effects of Mg particle concentration  were assessed. Samples containing 1% Mg by weight, 
3%wt Mg, 5%wt Mg, 10%wt Mg, and 20% wt Mg were produced. These compositions were 
visually compared and several observations were made. First it was observed that as Mg 
concentration increased, there was the presence of more gas bubbles in the samples (Fig 2.4). 
This is likely due to a proportional increase in gas being formed, leading to bubbles 
compounding into larger bubbles that aren’t able to escape the composite as easily. The 
increase in bubbles is not ideal because it weakens the composite mechanics, it is also 
expected the bubble release will continue at the same proportion in vivo. This indicates that the 
10% and 20% films may lead to the production of too much gas for the body to handle resulting 
in gas pocket formation as previously discussed. The second trend observed was an increase in 
composite uniformity with increasing concentration of Mg. The 1% and 3% had clear patterns of 
particle agglomeration, while films of 5%, 10%, and 20% appeared to be very uniform in 
composition. This phenomenon may be due to particle saturation, it may also be due in part to 
increasing particle repulsion as the number of particles increases. From the comparison it was 
evident that the 5% sample appears to be the ideal concentration due to it offering the best 
trade off between bubble formation and particle distribution.  
 
Figure 2.4- Images comparing the use of various concentrations of Mg A) 1% Mg by weight  B) 
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3%wt Mg C) 5%wt Mg D) 10%wt Mg E) 20%wt Mg. Two trends are observed, 1) an increase in 
bubble formation as Mg concentration increases, and 2) a decrease in observable particle 
agglomeration with increase in Mg concentration.  
 
  
Figure 2.5- A micrograph (40x) of the 5%wt Mg sample, which despite being produced with 
what was determined to be the ideal solvent at the ideal volume, there is still agglomeration 
throughout the sample (circled in red) on the microscopic level.  
 
2.5 Discussion 
 
Despite the improved macroscopic particle distribution observed from using Chloroform at 5 mL, 
there still exists Mg particle agglomeration on the microscopic level (Fig. 2.5). Although 
agglomeration has been reduced it is still a concern that should be addressed. In order to 
overcome this issue the use of a means to better integrate Mg particles into the PLGA matrix is 
needed. This can likely be accomplished through a chemical mediator. This will be further 
discussed in Chapter 4. 
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Chapter Three: Influence of Composite Composition on Degradation and Mechanics 
 
3.1 In vitro Degradation Study  
 
Degradation studies were performed to determine the influence of Mg concentration on the 
properties of PLGA-Mg composites. A study was performed comparing several compositions of 
Mg films in phosphate buffered saline (PBS). Magnesium concentration was varied between 
groups while PLGA was kept constant at 1g. Groups consisted of a PBS control, PLGA (85:15), 
PLGA with 1%wt Mg, PLGA 3%wt Mg, PLGA  5% wt Mg, and PLGA 10%wt Mg. 12mm diameter 
film punches were added to 10 mL of PBS in a test tube. pH was measured at least once for 
every two days, and a mean pH was calculated for each time point from three replicates for 
each group. A pH probe was used for measurements and was calibrated prior to each 
measurement. 
The samples were incubated in a 47°C water bath (10 degrees above physiological conditions) 
in order to accelerate degradation from taking approximately 1 year to only taking a couple 
months. It has been demonstrated that a temperature increase of 2 degrees Celsius can result 
in a 25-30% reduction in degradation time [5].   
 
The results of the study (Fig. 3.1) shows a direct correlation between magnesium concentration 
and the rate of composite degradation. The sample containing no Mg (PLGA alone) was found 
to fully degrade in about 35 days, while the 10%wt Mg sample was found to fully degrade in 
over twice the amount of time at about 75 days. This is in part a result of an increased pH early 
during the degradation process causing the film to more slowly degrade, this is due to PLGA’s 
pH influenced degradation, since PLGA degrades more rapidly in an acidic solution as 
previously discussed.  A second trend is also observed, there is a shift in pH towards the basic 
end of the spectrum as Mg concentration increases. Although there is a clear change in 
degradation behavior, it is still not certain that Mg is actually neutralizing the acidic byproducts. 
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It may actually just be shifting the curve leading to a delayed degradation. In addition it is 
possible all the Mg degrades entirely in the first week, after which it has no influence on the 
solution pH. In order to assess this a second degradation study with a modified profile was 
performed.  
 
 
Figure 3.1-Results of the degradation study with a clear demonstration of the ability to control 
PLGA degradation behavior through varying Mg concentration.  
 
3.2. In Vivo Simulation Degradation Study 
 
In the body an implanted material is subjected to the forces of homeostasis and immune 
response. Materials that are capable of being broken down are exposed to constant sink 
conditions where the body attempts to break down and remove the foreign object through 
continuous cycling of the surrounding fluid. In order to simulate in vivo conditions a degradation 
study was carried out in which the solution was fully replaced once per week. Although this isn’t 
a perfect model of body conditions, it is a starting point for assessing the effect of replacing 
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solution and is infrequent enough to allow for degradation to still occur in a reasonable amount 
of time.  
 
Only one composition of Mg was selected to be compared to PLGA alone. 5%wt Mg was picked 
due to the observations made while observing the effects of different Mg concentrations on film 
properties. Plotting pH against time revealed very different behavior between the two samples. 
The plot shows that the addition of Mg is enough to buffer the acidic byproducts of PLGA 
maintaining a pH between ~6 and 8.5, while the PLGA sample had a pH range of ~4 to 7.5 (Fig. 
3.2). It was also observed that the addition of Mg prolonged the rate of degradation. The PLGA 
sample degraded fully in 55 days, while the Mg containing sample fully degraded in 75 days. 
The two samples were also compared to the corresponding compositions from the original 
degradation study (Fig. 3.3). Just by replacing the PBS solution there was an observable 
change in degradation behavior. pH range was reduced, this suggested the expected, that in 
the body the range of pH will be reduced. It is also observed that the time for full degradation is 
longer in the samples where solution is replaced, also as expected. Based on these findings it 
can be concluded that when this composite is in the body it will degrade far more slowly and the 
pH range will be further compressed towards the physiological pH.  
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Figure 3.2- Results of the in vivo simulation degradation study. The plot shows that the 
presence of Mg in the composite can neutralize acidic byproducts of PLGA and slow the rate of 
composite degradation.  
 
Figure 3.3- Comparison of the in vitro degradation study to the in vivo simulation degradation 
study results. In vivo degradation time is observably longer than in vitro.  
 
 
 
 
16 
 
3.3 Tensile Testing and Mg Concentration 
 
To fulfill the first specific aim, tensile testing was performed to assess the influence of 
magnesium composition on film mechanics. Testing was performed on 13 mm by 6.5 mm and 
~.05 mm thick samples. To prepare the samples for testing, they were lyophilized for two weeks 
immediately after fabrication. This was done to ensure removal of the solvent in its entirety. 
Presence of the solvent effects mechanics by making samples more elastic, so it is important to 
make sure they are properly dried. Samples containing 3%wt Mg, 5%wt Mg, and 10%wt Mg 
were compared, with n=6 per each composition. The strips were stretched to 50% elongation 
and elastic modulus was recorded. To assess the results, one way analysis of variance 
(ANOVA) was used to compare all three groups at once, and Tukey’s Multiple Comparison Test 
was used to compare the groups to each other. ANOVA determined that the groups had very 
significant difference among them with p=.0006. Tukey’s Test revealed that the elastic modulus 
of the 10% group was significantly greater than the 3% group, and very significantly greater than 
the 1% (Fig. 3.4). The 3% and 1% groups were not found to be significantly different. This 
demonstrates that with an increase in Mg concentration the mechanics of the films can be 
improved making them stronger. This also shows that it is possible to tune the mechanical 
properties of the composite through changing Mg concentration alone.  
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Figure 3.4-. Comparison of the modulus of elasticity between three compositions of Mg. The 
10% samples show significant difference from the 3% and 1%, indicating that increase in Mg 
leads to increased strength of the composite.  
 
 
3.4 Influence of Bubbles on Composite Mechanics  
 
It was observed during the film fabrication process that an increasing concentration of Mg was 
shown to increase the formation of gas bubbles. This has several implications upon the 
mechanics of the composite. It is expected that an increase in number of bubbles in the 
composites would lead to weakening of mechanics. Having more gas pockets means the 
samples are structurally compromised with voids.  
 
3.5 Discussion 
 
Increasing Mg concentration was found to have several effects upon the properties of the 
composites. This demonstrates the ability for tunable degradation and mechanics of the films. 
By varying Mg concentration it is possible to prolong composite degradation allowing the body 
for a longer time to dispose of byproducts. It was also demonstrated that Mg directly influence 
mechanics of the composite allowing for composite strengthening. When used in osteogenic 
applications this could permit for fine tuning composites to be suitable for degradable bone 
scaffolds that degrade at the rate bone heals while matching the needed mechanics. 
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4. Chapter Four: Modification of Mg  
 
4.1 Self Assembling Monolayers 
 
To meet the second aim, Mg particle modification was investigated for the purpose of preventing 
particle agglomeration and prolonging their degradation. A literature search and review found a 
promising solution. A study by Grubac et al. demonstrated the use of alkylphosphonic acids as a 
self assembling monolayer (SAM) to coat the surface of a Mg alloy [23]. This coating was shown 
to increase the hydrophobicity of the metal surface.   
 
Alkylphosphonic acids have long carbon chain tails that are hydrophobic, while the molecule 
head is hydrophilic. Since the Mg is hydrophilic as well, the alkylphosphonic acid head is 
attracted to the Mg particle surface. Since the hydrophilic head is in toward the particle, the 
hydrophobic tail extends outward. It was hypothesized that phenomenon could be utilized to 
form a hydrophobic coating on our Mg particles. By having the coating in place it would be 
expected that the particles would be protected from water exposure, and thus prolong their 
degradation. It is also expected that the modification would allow for the Mg particles to be 
better integrated into the PLGA matrix. Since the hydrophobic tail extends out from the molecule 
and the matrix is hydrophobic as well, it is expected that the particles will become integrated into 
the matrix as shown in Figure 4.1. This integration will prevent the Mg particles from being freely 
passed from the matrix thus preventing them from agglomerating. 
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Figure 4.1- It is expected that the Mg particles will be integrated into the matrix by hydrophobic 
tails of the SAM layer interacting with the hydrophobic matrix.  
 
4.2 Modification Process Overview 
 
The modification process begins with dissolving the acid in ethanol. The Mg particles are then 
introduced and the solution is mixed to coat the particles. The liquid is then filtered out and the 
Mg particles are heated. The particles are heated at 120°C for at least six hours. The heating 
done to improve the strength of the modification.Grubac et al. demonstrated that heating for 24 
hours improves the bond strength by converting the phosphonic acid coating to a phosphonate 
[23].  
 
The acids decylphosphonic acid (DP) and octadecylphosphonic acid (ODP) were selected 
based on their success in the literature. DP has a 10 carbon chain, while ODP has an 18 carbon 
chain. ODP was demonstrated to have a greater hydrophobic effect, demonstrated by a higher 
contact angle with water when compared to the shorter chain acid [23]. This is likely due to the 
longer chain keeping water farther from the metal surface.  
 
During the film fabrication process it was hypothesized that the exposure of chloroform to the 
modified particles could be disrupting the bonds. To reduce this risk, the film fabrication protocol 
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was modified so that the Mg particles were added 45 minutes into mixing so that they would 
only be exposed to the high volume of solvent for a limited time.  
 
4.3 Modification Influence on Agglomeration 
 
To assess if the Mg particles were successful at preventing particle agglomeration, 
compositions containing both the DP modification and the ODP modification were compared to 
a sample containing unmodified Mg particles. Mg concentrations of 1%wt Mg, 5%wt Mg, and 
10%wt Mg were observed at 100x magnification (Fig. 4.2). There was no clear differences 
observed at 1% and 5% but at 10% there was a clear reduction in gas bubble formation with 
both reduced bubbles and reduced bubble size. This however is indicative that the modification 
may be preventing or delaying particle degradation. It was difficult to determine if particle 
agglomeration had actually been reduced because during the modification process it was 
observed that the solvent was causing Mg particles to stick together in clumps. When viewing 
the films micrographs it is difficult to determine the difference between these clumps and 
agglomerated particles. 
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Figure 4.2-A comparison of Mg to Mg modified with DP and ODP. There was an observed 
reduction in gas bubble formation in the 10% samples (bubbles appear with white outlines).  
 
 
4.4 Degradation Study on Modification 
 
To determine if there was an influence of modified particles on composite degradation behavior 
a degradation study was performed. Samples of the same concentrations as the original 
degradation study were used (1%, 3%, 5%, and 10%wt Mg) for both DP and ODP. The results 
were compared to unmodified Mg (Fig. 4.3, Fig. 4.4, Fig. 4.5, and Fig. 4.6). The modified 
samples at 1% and 3% showed no clear difference in behavior from the unmodified group. At 
5%, it is observed that the modified samples have slightly elevated pH during PLGA bulk 
degradation suggesting modification slightly delayed degradation. However this trend is 
reversed at 10% with the unmodified sample performing slightly more desirably. From these 
results it is not possible to make a conclusion about the success of modification. It is possible 
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that modification was successful but it is not having a strong enough effect to produce the 
composite behavior that was expected. 
 
 
 
Figure 4.3- A comparison of 1%wt Mg against modified Mg samples of the same 
concentrations. There appears to be no notable difference.  
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Figure 4.4- A comparison of 3%wt Mg against modified Mg samples of the same 
concentrations. There appears to be no notable difference. 
 
Figure 4.5- A comparison of 5%wt Mg against modified Mg samples of the same 
concentrations. There appears to be a slight difference during bulk degradation of PLGA (~day 
40). . 
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Figure 4.6- A comparison of 10%wt Mg against modified Mg samples of the same 
concentrations. There appears to be a slight difference during bulk degradation of PLGA (~day 
50-60), the unmodified sample group has slightly higher pH.  
 
4.6 Tensile Testing and Mg Modification 
 
The improved integration of the particles into the matrix is expected to lead to improved 
composite mechanics. In addition the improved particle integration is expected to reduce 
particle agglomeration and improve uniform particle dispersion which would improve composite 
mechanics. In order to assess the influence of the modification upon composite mechanics, 
tensile testing was performed on strips of film. Composite compositions of 3% and 10% were 
compared (Fig. 4.7). Samples were compared once again using ANOVA and Tukey’s Test. At 
3% there was no significant difference shown by ANOVA nor by the Tukey’s Test. However, at 
10% there was shown to be a significant difference (p=.0004) by ANOVA, and significant 
differences between 10%Mg and 10%ODP, and 10%DP and 10%ODP. These results provide 
mixed implications, there may or there may not be an association between modification and 
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mechanics. There may also only be an effect at higher concentrations of Mg, further testing is 
needed.    
 
 
Figure 4.7- Results of tensile testing of the modification at 3% and 10%. (n=5) 
 
4.7 FTIR 
 
Fourier transform infrared spectrometry (FTIR) was used to assess whether modification was 
successful. FTIR measures the absorbance of light by a material which allows for determination 
of molecular composition and structure. Samples of modified Mg were analyzed and a 
measurement from unmodified Mg was subtracted from the reading. The resulting plots are 
shown below for DP modified Mg (Fig. 4.8) and ODP modified Mg (Fig. 4.9). Peaks at ~2900 
and ~2850 are indicative of a methylene group. The intensities of the peaks are not very large 
but they still suggest the presence of some degree of successful modification. Further testing 
must be done with alternative methods to confirm this.  
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Figure 4.8-The resulting difference in FTIR spectra between Mg and Mg modified with DP.   
 
 
 
Figure 4.9- The resulting difference in FTIR spectra between Mg and Mg modified with ODP.   
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4.8 Saturation of Modification Solution 
 
Since the results of the degradation study, imaging, mechanical testing, and FTIR were 
inconclusive, the method of modification was reevaluated. The conclusion was reached that 
only some of the Mg particle surfaces were being modified.  It was then suggested that the 
factor influencing this was the concentration of the acid in the modification solution, since this 
variable had not been controlled during the process. ODP was found to saturate at 30 mM, DP 
however due to its lower molecular weight was found to easily exceed this this concentration 
and was able to reach 200 mM and greater. A hypothesis was developed; by using a shorter 
acid at a higher concentration more acid chains could be available in solution leading to more of 
the Mg surface getting coated (Fig. 4.10). This however leads to a tradeoff with hydrophobic 
strength, shorter chains would be expected to have weak hydrophobic forces. 
 
  
Figure 4.10- It was hypothesized that by using a shorter acid, more acid chains could be 
dissolved in solution (at the saturating point) allowing for more of the Mg particle surface to be 
coated.  
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To assess this hypothesis a third acid was introduced, hexylphosphonic acid (HP), with a six 
carbon chain. The three acids were compared by degradation, first by comparing all three at the 
same concentration of 30 mM (ODP saturation) then comparing HP to DP at over five times the 
concentration (200 mM). These two comparisons assess the influence of the hydrophobic chain 
length.  The results of the degradation studies are shown in Figure 4.11. When plotted, the 
results show that at 30 mM HP and DP performed very similarly but ODP performs slightly 
better. At 200 mM DP performed the same as HP up until the PLGA bulk degradation period at 
which point it showed a slightly more basic pH and prolonged degradation. At both 
concentrations, when compared to unmodified Mg, all the acids had a more basic pH and a 
comparatively prolonged degradation. Grubac et al. demonstrated that at the same 
concentration, an ODP coating on a Mg surface was more hydrophobic than a DP coating [23]. 
This appears to support the results of the degradation study.  
 
 
Figure 4.11- A comparison of the length of the acid and the degradation behavior. 
 
A third analysis was then made comparing HP and DP against themselves at the two 
concentrations to assess if there is an influence of concentration on degree of modification. 
When plotted the results showed comparable degradation up until the bulk degradation phase, 
at which the lower concentrations both had more acidic pHs and degraded slightly faster (Fig. 
4.12). Although there is a slight difference, it is hard to say whether the modification is truly 
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responsible. Further testing will be needed in which all three acids are brought to their saturation 
points during the modification process.  
 
 
Figure 4.12- A comparison of the concentration of acid used to modify the Mg particles. 
 
4.9 Discussion 
 
Modification was met with mixed results. Although it appeared to reduce hydrogen gas 
formation and bear some influence over degradation it is still not clear whether it was 
successful. Advanced methods of analysis such as x-ray photoelectron spectroscopy (XPS) will 
be used in the future to confirm. It is also possible that modification is only in part successful, 
covering only a fraction of the Mg surface. Some evidence of improving degradation through 
manipulation of acid chain length and concentration of acid were found. More research will have 
to be done to compare the performance of all three acids at their solution saturation points. If 
the modification can be properly controlled it can allow for an extra degree of Mg particle 
degradation protection which will prevent Mg from degrading so quickly. This will allow for 
longer buffering effect against acidic byproducts of PLGA and prolong degradation of the 
composite.  
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Chapter Five: Summary  
 
5.1 Conclusion 
 
This study demonstrated that through varying the Mg concentration of PLGA-Mg composites, 
byproduct formation and degradation rate can be controlled. As the concentration increases the 
time it takes the composition to degrade increases as well as the overall pH is elevated. In 
addition, through simulating in vivo sink conditions, it was proven that Mg oxide byproduct can 
be used to neutralize acid byproducts of PLGA. A sample containing 5%wt Mg was compared to 
a PLGA only sample. The 5% degraded fully in ~75 days compared to the PLGA which 
degraded fully in ~35 days. The pH range was also more neutral for the Mg sample (6-8.5) while 
the PLGA reached an acidic pH level (4-7.5). Through mechanical testing it was found that as 
Mg concentration increases, elastic modulus increases as well. 10%wt Mg samples were shown 
to have a significantly greater mean elastic modulus compared to that of 3% Mg (P<.01) and 
1%Mg (P<.001). Attempted use of particle modification to improve particle dispersion and 
prolong particle degradation showed mixed results. Micrographs of samples revealed a 
decrease in gas bubble formation in 10%wt Mg samples with modified Mg. FTIR found low 
intensity peaks at wavelengths indicating methyl group presence, suggesting some degree of 
successful modification. Degradation studies did not demonstrate any observable differences of 
the modified samples beyond a slightly slower bulk degradation phase of PLGA. Further 
investigation of the alkylphosphonic acid modification and alternative modification methods will 
be carried out in the future. Despite this setback the ability to control the composite’s properties 
has been demonstrated to be feasible through other means. Through its tunable properties this 
composite can be used in a range of applications as a novel biomaterial without the concern for 
degradation related issues.  
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5.2 Future Goals 
 
Moving forward there are still several important questions to address. To do this a cell study will 
be performed with MC3T3 (osteoblast progenitor) cells seeded onto 2D scaffolds of the 
composite. The initial tests will assess the performance of 5%wt Mg composites against PLGA 
alone, and 5%wt ZK61. Assays on cell proliferation will be performed to confirm neutral pH of 
the composite byproducts. A second assay will be performed to quantify mineralization to 
determine the osteogenic benefits of Mg. Lastly an assay will be performed to assess if the 
addition of Zn through the alloy introduces a significant level of antimicrobial defense.  
 
The results of the modification were inconclusive. As previously stated FTIR may be insufficient 
to determine if the modification is present on the particle surface. A different means of 
assessment will be used, XPS. XPS will be able to provide insight into the surface chemistry of 
the particles, by telling whether the alkylphosphonic acids are present.  
When assessing whether modification had any influence on particle agglomeration it was 
observed that modification process had lead to particle clumping. This clumping was nearly 
indistinguishable from the agglomeration so it was difficult to assess if agglomeration had truly 
been prevented. Future work will investigate the prevention of particle clumping during 
modification through careful control of the modification process. In addition alternative methods 
of surface modification will be investigated and compared to the use of alkylphosphonic acids.  
 
Lastly, the hypothesis that saturation of the modification solution having influence on the degree 
of particle surface coating, will be further explored. Both HP and DP will be brought to their 
saturation points and a degradation study will be carried out where they are compared to ODP 
also at saturation concentration. The results of this study will provide valuable insight into 
modification process allowing for improvement in the development of the composite.  
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